Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 593

1.

Sentinel lymph node biopsy and axillary dissection: added morbidity of the arm, shoulder and chest wall after mastectomy and reconstruction.

Sclafani LM, Baron RH.

Cancer J. 2008 Jul-Aug;14(4):216-22. doi: 10.1097/PPO.0b013e31817fbe5e. Review.

PMID:
18677128
2.

Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.

Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, Yiangou C, Horgan K, Bundred N, Monypenny I, England D, Sibbering M, Abdullah TI, Barr L, Chetty U, Sinnett DH, Fleissig A, Clarke D, Ell PJ.

J Natl Cancer Inst. 2006 May 3;98(9):599-609. Erratum in: J Natl Cancer Inst. 2006 Jun 21;98(12):876.

3.

Sentinel node biopsy and quality of life measures in a Chinese population.

Chen JJ, Huang XY, Liu ZB, Chen TW, Cheng JY, Yang WT, Xu WP, Shao ZM, Shen ZZ, Wu J.

Eur J Surg Oncol. 2009 Sep;35(9):921-7. doi: 10.1016/j.ejso.2009.01.009.

PMID:
19233602
4.

Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.

Husted Madsen A, Haugaard K, Soerensen J, Bokmand S, Friis E, Holtveg H, Peter Garne J, Horby J, Christiansen P.

Breast. 2008 Apr;17(2):138-47.

PMID:
17928226
5.
6.

Changes in arm morbidities and health-related quality of life after breast cancer surgery - a five-year follow-up study.

Sagen A, Kåresen R, Sandvik L, Risberg MA.

Acta Oncol. 2009;48(8):1111-8. doi: 10.3109/02841860903061691.

PMID:
19863218
7.

Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection--data from a prospective randomised trial.

Helms G, Kühn T, Moser L, Remmel E, Kreienberg R.

Eur J Surg Oncol. 2009 Jul;35(7):696-701. doi: 10.1016/j.ejso.2008.06.013.

PMID:
18838245
8.

Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy.

Schijven MP, Vingerhoets AJ, Rutten HJ, Nieuwenhuijzen GA, Roumen RM, van Bussel ME, Voogd AC.

Eur J Surg Oncol. 2003 May;29(4):341-50.

PMID:
12711287
9.

Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer.

Crane-Okada R, Wascher RA, Elashoff D, Giuliano AE.

Ann Surg Oncol. 2008 Jul;15(7):1996-2005. doi: 10.1245/s10434-008-9909-y.

PMID:
18415650
10.

The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance.

Leidenius M, Leivonen M, Vironen J, von Smitten K.

J Surg Oncol. 2005 Oct 1;92(1):23-31.

PMID:
16180231
11.

Subjective morbidity and quality of life after sentinel node biopsy and axillary lymph node dissection for breast cancer.

Barranger E, Dubernard G, Fleurence J, Antoine M, Darai E, Uzan S.

J Surg Oncol. 2005 Oct 1;92(1):17-22.

PMID:
16180226
12.

Swelling, numbness, pain, and their relationship to arm function among breast cancer survivors: a disablement process model perspective.

Bosompra K, Ashikaga T, O'Brien PJ, Nelson L, Skelly J.

Breast J. 2002 Nov-Dec;8(6):338-48.

PMID:
12390356
13.

Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer.

Rietman JS, Dijkstra PU, Geertzen JH, Baas P, de Vries J, Dolsma WV, Groothoff JW, Eisma WH, Hoekstra HJ.

Ann Surg Oncol. 2004 Nov;11(11):1018-24.

PMID:
15525832
14.

Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma.

Rietman JS, Dijkstra PU, Geertzen JH, Baas P, De Vries J, Dolsma W, Groothoff JW, Eisma WH, Hoekstra HJ.

Cancer. 2003 Aug 15;98(4):690-6. Erratum in: Cancer. Cancer. 2004 May 1;100(9):1991.

15.

Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy.

Nesvold IL, Dahl AA, Løkkevik E, Marit Mengshoel A, Fosså SD.

Acta Oncol. 2008;47(5):835-42. doi: 10.1080/02841860801961257.

PMID:
18568481
16.

Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection.

Golshan M, Martin WJ, Dowlatshahi K.

Am Surg. 2003 Mar;69(3):209-11; discussion 212.

PMID:
12678476
17.

Lymphedema following breast cancer treatment, including sentinel lymph node biopsy.

Armer J, Fu MR, Wainstock JM, Zagar E, Jacobs LK.

Lymphology. 2004 Jun;37(2):73-91.

PMID:
15328760
18.

Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.

Boneti C, Korourian S, Bland K, Cox K, Adkins LL, Henry-Tillman RS, Klimberg VS.

J Am Coll Surg. 2008 May;206(5):1038-42; discussion 1042-4. doi: 10.1016/j.jamcollsurg.2007.12.022.

PMID:
18471751
19.

The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer.

Rebegea L, Firescu D, Dumitru M, Anghel R.

Chirurgia (Bucur). 2015 Jan-Feb;110(1):33-7.

20.

Post lymphadenectomy complications and quality of life among breast cancer patients in Brazil.

Paim CR, de Paula Lima ED, Fu MR, de Paula Lima A, Cassali GD.

Cancer Nurs. 2008 Jul-Aug;31(4):302-9; quiz 310-1. doi: 10.1097/01.NCC.0000305747.49205.b1.

PMID:
18600117
Items per page

Supplemental Content

Support Center